All Stories

  1. In Silico ADMET Studies, Molecular Docking and Molecular Dynamics Simulation of Thiadiazole Derivatives for the Identification of Putative HsaA Monooxygenase Inhibitors

    Article • Current Medicinal Chemistry, March 2026, Bentham Science Publishers

    KETKI RANI

  2. Identification of N ‐(2‐(1H‐indol‐3‐yl) ethyl)‐ N ‐benzylacrylamide as Novel Aurora Kinase A Inhibitor for Cancer Therapy: Virtual Screening, Synthesis, MD Si...

    Article • ChemistrySelect, November 2025, Wiley

    KETKI RANI

  3. Advances in Molecular Docking Techniques for Targeting Protein Misfolding in Neurodegenerative Diseases

    Article • Current Pharmaceutical Biotechnology, August 2025, Bentham Science Publishers

    KETKI RANI

  4. Unlocking Therapeutic Potential: Molecular Docking Insights into Aurora Kinase A Inhibitors Patented and Published from 2011-2020 for Innovative Anticancer Drug Design

    Article • Letters in Drug Design & Discovery, December 2024, Elsevier

    KETKI RANI

  5. Synthesis, Molecular Docking, and Biological Evaluation of Novel Indole-triazole Conjugates

    Article • Current Drug Discovery Technologies, November 2024, Bentham Science Publishers

    KETKI RANI

  6. Harnessing Computational Modeling for Efficient Drug Design Strategies

    Article • Letters in Organic Chemistry, June 2024, Bentham Science Publishers

    KETKI RANI

  7. Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review

    Article • Behavioural Neurology, October 2023, Hindawi Publishing Corporation

    KETKI RANI

  8. In Silico and In Vitro Screening of Novel Pyridazine Analogs as Muscle Relaxant Agent on Acetylcholine Muscarinic Receptor

    Article • Letters in Drug Design & Discovery, June 2023, Bentham Science Publishers

    AVIJIT MAZUMDER, KETKI RANI

  9. Docking Studies of Potent Xanthine Oxidase Inhibitors-Molecules Patented and Published from 2011-2020

    Article • Oriental Journal Of Chemistry, August 2022, Oriental Scientific Publishing Company

    KETKI RANI

  10. QSAR study on 4-alkynyldihydrocinnamic acid analogs as free fatty acid receptor 1 agonists and antidiabetic agents: Rationales to improve activity

    Article • Arabian Journal of Chemistry, November 2019, Elsevier

    KETKI RANI